Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

A team of University of Kentucky Markey Cancer Center researchers has found the mechanism that grants prostate cancer ...

Researchers have long explored ways to prevent and treat prostate cancer, one of the most common cancers in men. For years, ...

Elevated PSA levels can signal both malignant and benign prostate cancer But what does it mean if the PSA levels rise after a ...

“Building on decades of research into the genetic markers of prostate cancer, our study shows that the theory does work in ...

A Nigerian researcher, Dr Jerry Adeyemo, has identified alternative therapies that could help in the treatment of prostate ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

SpaceOAR Hydrogel reduced the risk of bowel disorders, the need for colonoscopy and rectal resection following radiation therapy in prostate cancer. First patient dosed in phase 1b/2a trial for ...

A prostate cancer spit test has brought a national screening programme for the disease a step closer, experts have said. The ...

Patients with prostate cancer may differ in time to testosterone recovery, depending on the length of treatment and age, but takes six months on average. It’s crucial for patients with prostate cancer ...